Skip to main navigation
Skip to search
Skip to main content
University of Eastern Piedmont Home
Italiano
English
Search content at University of Eastern Piedmont
Home
Profiles
Research units
Equipment
Projects
Research output
Back from the brink: EGFR inhibition in gastroesophageal cancer
Mark R. Openshaw
,
David J. Pinato
, Nicola Valeri
Department of Translational Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Back from the brink: EGFR inhibition in gastroesophageal cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Difficult-to-treat
50%
EGFR Inhibition
100%
EGFR Inhibitors
100%
Gastroesophageal Adenocarcinoma
100%
Gastroesophageal Cancer
100%
Randomized Trial
50%
Targeted Therapeutics
50%
Medicine and Dentistry
Adenocarcinoma
100%
EGFR Inhibitors
100%
Epidermal Growth Factor Receptor
100%
Malignant Neoplasm
100%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
66%
Epidermal Growth Factor Receptor
100%
Malignant Neoplasm
100%